BioCryst Pharmaceuticals | BCRX - PE Price to Earnings


BioCryst Pharmaceuticals reported 1.08K in PE Price to Earnings for its fiscal quarter ending in December of 2022.





Pe Change Date
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Chugai Pharma JPY 31.26 5.24 Dec/2025
Daiichi Sankyo JPY 20.73 1.74 Dec/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novavax 2.28 346.03 Mar/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sarepta Therapeutics USD 27.27 0 Sep/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025